Michael Moran

4PUBLICATIONS
14CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 08, 2026
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up.

Jennifer A Woyach, Relja Popovic, Emily L Rossi

|Jan 30, 2024
Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemia.

Stephan Stilgenbauer, Eugen Tausch, Andrew W Roberts

|Nov 23, 2021
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis.

Barbara Melosky, Kato Kambartel, Maik Häntschel

|Mar 16, 2021
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry.

Arne Strauss, Marianne Schmid, Michael Rink

Pageof 1